Catherine Novack
Stock Analyst at Jones Trading
(1.54)
# 3,215
Out of 4,734 analysts
16
Total ratings
28.57%
Success rate
-9.39%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Catherine Novack
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KRRO Korro Bio | Initiates: Buy | $130 | $37.00 | +251.35% | 1 | Nov 18, 2024 | |
| CAPR Capricor Therapeutics | Initiates: Buy | $40 | $13.70 | +191.97% | 1 | Nov 18, 2024 | |
| EQ Equillium | Downgrades: Hold | n/a | $0.64 | - | 1 | Nov 1, 2024 | |
| WVE Wave Life Sciences | Maintains: Buy | $12 → $16 | $10.99 | +45.59% | 2 | Sep 25, 2024 | |
| LRMR Larimar Therapeutics | Initiates: Buy | $14 | $3.34 | +319.16% | 1 | Sep 12, 2024 | |
| DARE Daré Bioscience | Maintains: Buy | $5 → $13 | $3.34 | +289.22% | 2 | Aug 16, 2024 | |
| RGLS Regulus Therapeutics | Initiates: Buy | $8 | $1.24 | +545.16% | 1 | May 31, 2024 | |
| RZLT Rezolute | Initiates: Buy | $10 | $4.87 | +105.34% | 1 | Apr 18, 2024 | |
| FEMY Femasys | Maintains: Buy | $7 → $10 | $1.11 | +800.90% | 1 | Mar 20, 2024 | |
| CALC CalciMedica | Initiates: Buy | $22 | $3.09 | +611.97% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $6.19 | - | 2 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $160 | $3.54 | +4,419.77% | 1 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $0.55 | +1,903.64% | 1 | Mar 10, 2023 |
Korro Bio
Nov 18, 2024
Initiates: Buy
Price Target: $130
Current: $37.00
Upside: +251.35%
Capricor Therapeutics
Nov 18, 2024
Initiates: Buy
Price Target: $40
Current: $13.70
Upside: +191.97%
Equillium
Nov 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $0.64
Upside: -
Wave Life Sciences
Sep 25, 2024
Maintains: Buy
Price Target: $12 → $16
Current: $10.99
Upside: +45.59%
Larimar Therapeutics
Sep 12, 2024
Initiates: Buy
Price Target: $14
Current: $3.34
Upside: +319.16%
Daré Bioscience
Aug 16, 2024
Maintains: Buy
Price Target: $5 → $13
Current: $3.34
Upside: +289.22%
Regulus Therapeutics
May 31, 2024
Initiates: Buy
Price Target: $8
Current: $1.24
Upside: +545.16%
Rezolute
Apr 18, 2024
Initiates: Buy
Price Target: $10
Current: $4.87
Upside: +105.34%
Femasys
Mar 20, 2024
Maintains: Buy
Price Target: $7 → $10
Current: $1.11
Upside: +800.90%
CalciMedica
Feb 16, 2024
Initiates: Buy
Price Target: $22
Current: $3.09
Upside: +611.97%
Oct 5, 2023
Downgrades: Hold
Price Target: n/a
Current: $6.19
Upside: -
Jul 21, 2023
Initiates: Buy
Price Target: $160
Current: $3.54
Upside: +4,419.77%
Mar 10, 2023
Initiates: Buy
Price Target: $11
Current: $0.55
Upside: +1,903.64%